Target Name: MYL4
NCBI ID: G4635
Review Report on MYL4 Target / Biomarker Content of Review Report on MYL4 Target / Biomarker
MYL4
Other Name(s): ALC1 | atrial myosin light chain 1 | MYL4 variant 2 | MYL4_HUMAN | Myosin light chain alkali GT-1 isoform | Myosin, atrial/fetal muscle, light chain | AMLC | myosin, light chain 4, alkali; atrial, embryonic | PRO1957 | myosin, atrial/fetal muscle, light chain | myosin, light polypeptide 4, alkali; atrial, embryonic | MYL4 variant 1 | myosin light chain 4 | Myosin light polypeptide 4 | GT1 | Myosin light chain 1, embryonic muscle/atrial isoform | Myosin light chain 4

MYL4: A Versatile Protein Involved in Multiple Physiological Processes

MYL4 (also known as ALC1) is a protein that is expressed in various tissues throughout the body, including the brain, lungs, heart, and kidneys. It is a member of the myelin basic protein (MBP) family, which is a group of transmembrane proteins that are involved in the development and maintenance of the myelin sheath surrounding the neural fibers.

MYL4 is unique among the MBP family because of its unique structure and function. It has a five-pass transmembrane structure, which allows it to interact with a variety of different signaling molecules. It also has a unique kinetic profile, with a slow rate of translation and a rapid rate of degradation.

MYL4 is involved in a variety of physiological processes in the body, including the development and maintenance of the myelin sheath, the regulation of pain and inflammation, and the regulation of cell growth and differentiation. It is also involved in the development and maintenance of various tissues, including the brain and the kidneys.

One of the most promising aspects of MYL4 is its potential as a drug target. MYL4 has been shown to play a role in a variety of diseases, including multiple sclerosis, pain, and inflammation. It is also involved in the development of certain types of cancer, such as neuroblastoma.

MYL4 has also been shown to be a potential biomarker for a variety of diseases. Its expression has been detected in a variety of diseases, including multiple sclerosis, pain, and cancer. It is also has been shown to be expressed in the brains of individuals with certain genetic conditions, such as Alzheimer's disease and Parkinson's disease.

MYL4 is also involved in the regulation of cellular signaling pathways. It has been shown to interact with a variety of different signaling molecules, including TGF-beta, PDGF, and NF-kappa-B. are involved in the development and maintenance of the myelin sheath, including the regulation of neurotrophin signaling.

MYL4 is also involved in the regulation of the immune system. It has been shown to interact with immune cells and to play a role in the regulation of the immune response.

In conclusion, MYL4 is a unique and important protein that is involved in a variety of physiological processes in the body. Its potential as a drug target and biomarker make it an attractive target for research and development. Further studies are needed to fully understand the role of MYL4 in various diseases and to develop effective treatments.

Protein Name: Myosin Light Chain 4

Functions: Regulatory light chain of myosin. Does not bind calcium

The "MYL4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MYL4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MYL5 | MYL6 | MYL6B | MYL7 | MYL9 | MYLIP | MYLK | MYLK-AS1 | MYLK-AS2 | MYLK2 | MYLK3 | MYLK4 | MYLKP1 | MYMK | MYMX | MYNN | MYO10 | MYO15A | MYO15B | MYO16 | MYO16-AS1 | MYO16-AS2 | MYO18A | MYO18B | MYO19 | MYO1A | MYO1B | MYO1C | MYO1D | MYO1E | MYO1F | MYO1G | MYO1H | MYO3A | MYO3B | MYO3B-AS1 | MYO5A | MYO5B | MYO5C | MYO6 | MYO7A | MYO7B | MYO9A | MYO9B | MYOC | MYOCD | MYOD1 | MYOF | MYOG | MYOM1 | MYOM2 | MYOM3 | MYORG | Myosin | Myosin class II | Myosin light-chain phosphatase | MYOSLID | MYOSLID-AS1 | MYOT | MYOZ1 | MYOZ2 | MYOZ3 | MYPN | MYPOP | MYRF | MYRF-AS1 | MYRFL | MYRIP | MYSM1 | MYT1 | MYT1L | MYT1L-AS1 | MYZAP | MZB1 | MZF1 | MZF1-AS1 | MZT1 | MZT2A | MZT2B | N-acetylglucosamine-1-phosphotransferase | N-CoR deacetylase complex | N-Terminal Acetyltransferase A (NatA) Complex | N-Terminal Acetyltransferase C (NatC) Complex | N-Type Calcium Channel | N4BP1 | N4BP2 | N4BP2L1 | N4BP2L2 | N4BP2L2-IT2 | N4BP3 | N6AMT1 | NAA10 | NAA11 | NAA15 | NAA16 | NAA20 | NAA25 | NAA30 | NAA35 | NAA38